跳至主要内容
临床试验/PACTR201008000246399
PACTR201008000246399招募中未知

The Role of pentoxifylline as an Anti Tumor Necrosis Factor-¿ In Improving the Outcome of Depressed Elderly Treated With Selective Serotonin Reuptake Inhibitors: a pilot randomized, double-blinded, placebo controlled trial

Faculty of Medicine, Ain Shams University0 个研究点目标入组 40 人开始时间: 2010年7月30日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 Year(s) 至 85 Year(s)(—)
性别
All

入选标准

  • Age above 60 yrs
  • Depression according to DSM-IV criteria
  • At least moderate severity of depression as assessed by HDS and GDS

排除标准

  • Liver cell dysfunction by clinical evaluation and ¿ 3 fold ALT.
  • Compromised renal function (creatinine clearance less than 50 mL/minute, as estimated by the MDRD calculator).
  • Reported history of arrhythmias
  • Use of corticosteroids or high dose of any NSAID in the last 3 months.

研究者

相似试验